Peripheral circulating proteomic profiling reveals serum CD80 is positively correlated with the efficacy of neoadjuvant PD-1 blockade combined with chemotherapy for esophagus cancer.

ABSTRACT:

SUBMITTER: Wu L 

PROVIDER: S-EPMC12535015 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature